Myovant Sciences Ltd. that Kim Sablich, formerly Vice President of Primary Care Marketing in the United States for GlaxoSmithKline (GSK), will join Myovant Sciences as Chief Commercial Officer, and Jeff Nornhold, formerly Senior Vice President of Technical Operations for Impax Laboratories has joined Myovant as Senior Vice President of Pharmaceutical Operations & Development. In addition, Myovant has appointed industry veterans Myrtle Potter, Mark Guinan, and Frank Torti, to Myovant's Board of Directors, and Ms. Potter has been appointed Chairman of the Board.